CoChat

EU HTA Regulation and Joint Clinical Assessment—Threat or Opportunity?

Open access
Schuster, Volker · 2024 · Journal of Market Access & Health Policy

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

The vision of a unified European HTA is by no means a new endeavor. At its core are the publicly declared ambitions to harmonize assessments of clinical data within the EU and avoid the duplication of efforts. Not surprisingly, these ambitions are publicly announced to be motivating the new 2022 EU HTA regulation. However, industry experts typically see more of a risk for additional bureaucracy resulting in delays, further scrutiny, and one additional EU (clinical) dossier to submit on top of all national HTA dossiers, which could be considered a duplication of effort and therefore counterproductive. Regardless of how the details of the process will be defined and how the entire process will work in practice, we can be sure that EU officials will refer to the EU HTA and Joint Clinical Assessment (JCA) in particular as a learning system. The purpose of this article is to take a closer look at the new EU HTA regulation and analyze threats and opportunities for manufacturers and what the resulting opportunities and threats will be at the affiliate level throughout the EU.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jmahp12020008

Cites

0 of 4 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Above: General process overview of the Joint Clinical Assessment.
Figure 1 Above: General process overview of the Joint Clinical Assessment.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • (2023, December 16). Regulation (EU) 2021/2282 of the European Parliament and of the Council of 15 December 2021 on Health Technology Assessment and Amending Directive 2011/24/EU. Available online: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32021R2282.

    (n.d.)

    Unresolved
  • (2023, December 16). EUnetHTA 21, Practical Guideline D4.2 Scoping Process, Version 1.0, Sep 12, 2022 (Template Version Sep 30, 2021). Available online: https://www.eunethta.eu/wp-content/uploads/2022/09/EUnetHTA-21-D4.2-practical-guideline-on-scoping-process-v1.0.pdf.

    (n.d.)

    Unresolved
  • (2023, December 17). EUnetHTA, D5.1 JCA/CA, Submission Dossier Template, Version 1.0. Available online: https://www.eunethta.eu/wp-content/uploads/2021/12/EUnetHTA-21-D5.1-JCA_CA-Submission-Dossier-Template-Project-Plan-v1.0.pdf.

    (n.d.)

    Unresolved
  • (2023, December 17). EUnetHTA 21, D5.1, Submission Dossier Guidance, Version 1.0. Available online: https://www.eunethta.eu/wp-content/uploads/2022/12/EUnetHTA-21-D5.1-Submission-Dossier-Guidance-v1.0.pdf.

    (n.d.)

    Unresolved

Show all 4 references

Cited by

See all 27

Metadata

Authors
Schuster, V.
Affiliations
SAI MedPartners, Reading, PA 19606, USA
Corresponding author
Schuster, Volker
Venue
Journal of Market Access & Health Policy
Publisher
MDPI AG
Published
2024-05-13
Volume
12
Issue
2
Pages
100-104
ISSN
2001-6689 (ISSN-L)
OpenAlex
W4396938377
Cited by
22
References
4
Citations by year
2026: 11 · 2025: 10 · 2024: 1
FWCI
7.79
Type
journal article
Language
en
Open access
Locations
  • Journal of Market Access & Health Policy (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Healthcare Regulation
Keywords
EU HTA Regulation, Joint Clinical Assessment, pharmaceutical manufacturers, regulatory burden, learning systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: EU HTA Regulation and Joint Clinical Assessment—Threat or Opportunity? https://app.cochat.ai/papers/10.3390/jmahp12020008
The paper
Schuster, V. (2024). EU HTA Regulation and Joint Clinical Assessment—Threat or Opportunity? Journal of Market Access & Health Policy. https://doi.org/10.3390/jmahp12020008

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.